Research ArticleArticle
Circulating Fibroblast Growth Factor-21 Levels in Rheumatoid Arthritis: Associations With Disease Characteristics, Body Composition, and Physical Functioning
Patrick W. Gould, Babette S. Zemel, Elena G. Taratuta and Joshua F. Baker
The Journal of Rheumatology November 2020, jrheum.200673; DOI: https://doi.org/10.3899/jrheum.200673
Patrick W. Gould
JFB was supported by a Veterans Affairs Clinical Science Research and Development Career Development Award and VA Merit Award (IK2 CX000955, I01 CX001703), and by the University of Pennsylvania Clinical and Translational Research Center (UL1 RR024134). Research reported in this publication was supported by the National Center for Advancing Translational Sciences of the National Institutes of Health under award number UL1TR001878. The contents of this work do not represent the views of the Department of Veterans Affairs or the US Government. P.W. Gould, BA, E.G. Taratuta, MD, Perelman School of Medicine, University of Pennsylvania; B.S. Zemel, PhD, Perelman School of Medicine, University of Pennsylvania, and Children’s Hospital of Philadelphia; J.F. Baker, MD, MSCE, Perelman School of Medicine, University of Pennsylvania, Philadelphia VA Medical Center, Division of Rheumatology, University of Pennsylvania, and Department of Epidemiology and Biostatistics, University of Pennsylvania, Philadelphia, Pennsylvania, USA. The authors declare no conflicts of interest. Address correspondence to Dr. J.F. Baker, 5th Floor White Building, 3400 Spruce Street, Philadelphia, PA 19104, USA. Email: Joshua.Baker@pennmedicine.upenn.edu. Accepted October 21, 2020.
Babette S. Zemel
JFB was supported by a Veterans Affairs Clinical Science Research and Development Career Development Award and VA Merit Award (IK2 CX000955, I01 CX001703), and by the University of Pennsylvania Clinical and Translational Research Center (UL1 RR024134). Research reported in this publication was supported by the National Center for Advancing Translational Sciences of the National Institutes of Health under award number UL1TR001878. The contents of this work do not represent the views of the Department of Veterans Affairs or the US Government. P.W. Gould, BA, E.G. Taratuta, MD, Perelman School of Medicine, University of Pennsylvania; B.S. Zemel, PhD, Perelman School of Medicine, University of Pennsylvania, and Children’s Hospital of Philadelphia; J.F. Baker, MD, MSCE, Perelman School of Medicine, University of Pennsylvania, Philadelphia VA Medical Center, Division of Rheumatology, University of Pennsylvania, and Department of Epidemiology and Biostatistics, University of Pennsylvania, Philadelphia, Pennsylvania, USA. The authors declare no conflicts of interest. Address correspondence to Dr. J.F. Baker, 5th Floor White Building, 3400 Spruce Street, Philadelphia, PA 19104, USA. Email: Joshua.Baker@pennmedicine.upenn.edu. Accepted October 21, 2020.
Elena G. Taratuta
JFB was supported by a Veterans Affairs Clinical Science Research and Development Career Development Award and VA Merit Award (IK2 CX000955, I01 CX001703), and by the University of Pennsylvania Clinical and Translational Research Center (UL1 RR024134). Research reported in this publication was supported by the National Center for Advancing Translational Sciences of the National Institutes of Health under award number UL1TR001878. The contents of this work do not represent the views of the Department of Veterans Affairs or the US Government. P.W. Gould, BA, E.G. Taratuta, MD, Perelman School of Medicine, University of Pennsylvania; B.S. Zemel, PhD, Perelman School of Medicine, University of Pennsylvania, and Children’s Hospital of Philadelphia; J.F. Baker, MD, MSCE, Perelman School of Medicine, University of Pennsylvania, Philadelphia VA Medical Center, Division of Rheumatology, University of Pennsylvania, and Department of Epidemiology and Biostatistics, University of Pennsylvania, Philadelphia, Pennsylvania, USA. The authors declare no conflicts of interest. Address correspondence to Dr. J.F. Baker, 5th Floor White Building, 3400 Spruce Street, Philadelphia, PA 19104, USA. Email: Joshua.Baker@pennmedicine.upenn.edu. Accepted October 21, 2020.
Joshua F. Baker
JFB was supported by a Veterans Affairs Clinical Science Research and Development Career Development Award and VA Merit Award (IK2 CX000955, I01 CX001703), and by the University of Pennsylvania Clinical and Translational Research Center (UL1 RR024134). Research reported in this publication was supported by the National Center for Advancing Translational Sciences of the National Institutes of Health under award number UL1TR001878. The contents of this work do not represent the views of the Department of Veterans Affairs or the US Government. P.W. Gould, BA, E.G. Taratuta, MD, Perelman School of Medicine, University of Pennsylvania; B.S. Zemel, PhD, Perelman School of Medicine, University of Pennsylvania, and Children’s Hospital of Philadelphia; J.F. Baker, MD, MSCE, Perelman School of Medicine, University of Pennsylvania, Philadelphia VA Medical Center, Division of Rheumatology, University of Pennsylvania, and Department of Epidemiology and Biostatistics, University of Pennsylvania, Philadelphia, Pennsylvania, USA. The authors declare no conflicts of interest. Address correspondence to Dr. J.F. Baker, 5th Floor White Building, 3400 Spruce Street, Philadelphia, PA 19104, USA. Email: Joshua.Baker@pennmedicine.upenn.edu. Accepted October 21, 2020.
Article Figures & Data
Additional Files
In this issue
The Journal of Rheumatology
Vol. 51, Issue 4
1 Apr 2024
Circulating Fibroblast Growth Factor-21 Levels in Rheumatoid Arthritis: Associations With Disease Characteristics, Body Composition, and Physical Functioning
Patrick W. Gould, Babette S. Zemel, Elena G. Taratuta, Joshua F. Baker
The Journal of Rheumatology Nov 2020, jrheum.200673; DOI: 10.3899/jrheum.200673
Circulating Fibroblast Growth Factor-21 Levels in Rheumatoid Arthritis: Associations With Disease Characteristics, Body Composition, and Physical Functioning
Patrick W. Gould, Babette S. Zemel, Elena G. Taratuta, Joshua F. Baker
The Journal of Rheumatology Nov 2020, jrheum.200673; DOI: 10.3899/jrheum.200673